Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Neurochem. 2017 Feb 2;140(5):776–786. doi: 10.1111/jnc.13946

Figure 3.

Figure 3

Brain water content at 72 hours after GMH in rats treated with fingolimod (1.0 mg/kg), the S1PR1 agonist, or in rats co-administered fingolimod with a S1PR1/3/4 antagonist or a Rac1 inhibitor. Data expressed as mean ± SD. N=7 rats/group. * P<0.05 versus sham. † P<0.05 versus vehicle. & P<0.05 versus fingolimod. # P<0.05 versus S1PR1 Agonist.